Progress in primary CNS lymphoma.
O'Brien
Peter C
PC
Department of Radiation Oncology, Calvary Mater Newcastle, NSW 2310, Australia. peter.obrien@mater.health.nsw.gov.au
Seymour
John F
JF
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D003561:Cytarabine / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D008727:Methotrexate